In summary, our study has developed a predictive model incorporating age, AMH, bFSH, and insulin as indicators to estimate the probability of suboptimal response in PCOS patients undergoing the GnRH-antagonist protocol. Here, GNRH1 is linked to polycystic ovary syndrome.